Search Results
Aug 27, 2026, 05:05 ET Northstar Awarded New Patent for Proprietary Asphalt Shingle Reprocessing Technology
technology; (ii) the Company's plans to provide alternative sources of materials to customers in order to meet customer sustainability objectives; (iii) the Company's plans to file patents in North America and internationally; (iv) the Company's plans to process used or defective shingles into their
More news about: Northstar Clean Technologies Inc.
Aug 27, 2026, 00:41 ET 엑사이트 우라늄, 서스캐처원주 돈 레이크 우라늄 프로젝트 첫 시추공에서 최대 51978cps의 이상 방사능 검출 발표
Sopris("2SNA-1000") 시추공 스펙트럼 감마 프로브로 측정 시 900cps 초과, (ii) 비버로지 유형이나 기반암 함유형 애서배스카(Athabasca) 부정합면 관련 우라늄 매장지에 일반적으로 나타나는 구조, 열수 변질, 우라늄 광화 작용을 동반, (iii) RS-230 또는 2SNA-1000 프로브를 통한 분광 분석 결과 우라늄이 주된 원천임을 나타낸다.
More news about: Xcite Uranium Inc.
Aug 26, 2026, 21:10 ET DVLT Investors Have Opportunity to Lead Datavault AI Inc. Securities Fraud Lawsuit
overstated the volume of trading activity on the Datavault Platform, which was in fact minimal; (3) Datavault's undisclosed connections with Edward Withrow III, a convicted felon, when revealed, would cause Datavault AI to incur reputational harm; and (4) as a result, defendants' public statements
More news about: THE ROSEN LAW FIRM, P. A.
Aug 26, 2026, 19:55 ET PNR INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Pentair plc and Announces Opportunity for Investors with Substantial Losses to Lead the Pentair Class Action Lawsuit
which had more than offset any purported benefits to Pentair's business and financial results as a result of the implementation of the 80/20 program; (iii) Pentair's implementation of the 80/20 program had caused certain of its remaining Pool customers to buy inventory in excess of their current needs in
More news about: Robbins Geller Rudman & Dowd LLP
Aug 26, 2026, 16:05 ET Synopsys Posts Financial Results for Third Quarter Fiscal Year 2026
exercise of the related stock-based awards and, therefore, is not used by management to assess the core profitability of our business operations.(iii) Acquisition/divestiture related items. In connection with certain of our business combinations and/or divestitures, we incur significant expenses
More news about: Synopsys, Inc.
Aug 26, 2026, 12:13 ET Thurston Group Partners with Pixel Health, a Leading Healthcare IT Consulting and Managed Services Provider
Health delivers its end-to-end solution through three primary functions: (i) Strategy and Transformation Consulting, (ii) Managed IT Services, and (iii) Product Sales / Licensing."Our entrance into the healthcare IT services space reflects Thurston's commitment to partnering with leaders across
More news about: Thurston Group
Aug 26, 2026, 11:20 ET Wiley Rein LLP Reports that CBP Announces Additional Interim Measures to Combat Duty Evasion on Golf Carts from China
transshipment, all of which are illegal under the U.S. trade laws.For more information, please contact:Robert E. DeFrancesco, III[email protected]
More news about: Wiley Rein LLP
Aug 26, 2026, 10:49 ET Graviton BioScience Corporation Announces Publication of Positive Ph1b Trial Results for GV101 (TDI01) in Chronic Graft versus Host Disease in Signal Transduction and Targeted Therapy, by Beijing Tide Pharmaceutical
leukopenia, thrombocytopenia, or anemia, and only one grade 3 neutropenia. There were no CMV infections.Next: Graviton is currently in Phase III RCT planning for GV101 in cGvHD and plans to carry the high dose forward.About Chronic Graft versus Host DiseasecGvHD is a rare,
More news about: Graviton BioScience Corporation
Aug 26, 2026, 10:41 ET Oncolytic Virus Cancer Therapy Market Expected to Expand Rapidly During the Forecast Period (2026-2036) Amid Rising Investments in Next-Generation Cancer Treatments| DelveInsight
administered intravesically and is being studied in the Phase III BOND-003 trial for patients with Bacillus Calmette–Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC). It is also being evaluated as a monotherapy in the Phase III PIVOT-006 trial for patients with intermediate-risk NMIBC.
More news about: DelveInsight Business Research, LLP
Aug 26, 2026, 10:31 ET Congenital Hyperinsulinism Market to Expand at a CAGR of 12% During the Forecast Period (2026-2036) as Rising Disease Recognition and Novel Therapies Fuel Market Growth | DelveInsight
activity and help maintain stable blood glucose levels in patients with congenital hyperinsulinism. The therapy is currently being evaluated in Phase III clinical development. It has received multiple regulatory designations, including Breakthrough Therapy Designation (BTD), the UK's Innovative
More news about: DelveInsight Business Research, LLP
Aug 26, 2026, 10:12 ET Teragen Energy Raises Oversubscribed $6M Pre-Seed Round to Power Today's Frontier Industries
trilemma, offering a lower carbon, reliable, dynamic power solution with compelling economics," said Joshua James, Investor at BEVC.Victor Pascucci III, Managing General Partner at Energy Capital Ventures® said, "The natural gas industry is the backbone of the energy expansion. The industry
More news about: Teragen Energy
Aug 26, 2026, 10:07 ET REGN Shareholder Alert: Regeneron Pharmaceuticals, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky
pembrolizumab historical median PFS of approximately 4 to 5 months.The Alleged Reality: Phase III Results Did Not Match the NarrativeAs alleged, the Phase III study's prolonged slowdown in PFS event accrual did not support the optimistic interpretation presented to
More news about: Levi & Korsinsky, LLP
Aug 26, 2026, 09:26 ET Bernstein Litowitz Berger & Grossmann LLP Announces Notice of Pendency and Proposed Settlement Involving All Persons and Entities Who Purchased or Otherwise Acquired Ordinary Shares of Kornit Digital Ltd. From February 17, 2021 through July 5, 2022, Inclusive
SUMMARY NOTICE OF (I) PENDENCY OF CLASS ACTION AND PROPOSED SETTLEMENT; (II) SETTLEMENT HEARING; AND (III) MOTION FOR ATTORNEYS' FEES AND LITIGATION EXPENSESTO: All persons and entities who purchased or otherwise acquired the ordinary
More news about: JND Legal Administration
Aug 26, 2026, 09:00 ET JACKSON AND CHARVEL DEBUT SLEEP TOKEN SIGNATURE GUITAR AND BASS
Charvel Sleep Token III Signature Pro-Mod San Dimas® Bass V, marking the first-ever signature collaboration with globally acclaimed phenomenon
More news about: Fender Musical Instruments Corporation
Aug 26, 2026, 09:00 ET If you live in the United States and your Private Information may have been impacted in the Data Incident involving the ConnectOnCall Platform that occurred between February 16, 2024 and May 12, 2024, you may be entitled to benefits from a Settlement
with a healthcare provider or their office between May 12, 2014 and May 12, 2024, and incurred documented losses related to the Data Incident; and (iii) provide a description of the documented losses along with supporting documentation that is not self-prepared. To receive the alternate payment of up
More news about: United States District Court for the Eastern District of New York
Aug 26, 2026, 08:00 ET Solace Announces Appointment of Mike Capone to Board of Directors
was co-led by Apogem Capital, Golub Capital, HSBC Asset Management, and Schroders Capital, with meaningful participation from Bridge Growth Partners III, Bridge Growth's latest flagship fund, which made its inaugural investment through the transaction.Capone most recently served for more than eight
More news about: Solace Corporation
Aug 26, 2026, 08:00 ET Solace Announces Appointment of Mike Capone to Board of Directors
was co-led by Apogem Capital, Golub Capital, HSBC Asset Management, and Schroders Capital, with meaningful participation from Bridge Growth Partners III, Bridge Growth's latest flagship fund, which made its inaugural investment through the transaction.Capone most recently served for more than eight
More news about: Solace Corporation
Aug 26, 2026, 06:50 ET JinkoSolar Announces Second Quarter 2026 Financial Results
(US$134.2 million), which excludes the impact of (i) the change in fair value of long-term investment, (ii) gain from disposal of a subsidiary, and (iii) share-based compensation expenses, compared with adjusted net loss attributable to JinkoSolar Holding Co., Ltd.'s ordinary shareholders of RMB549.3
More news about: JinkoSolar Holding Co., Ltd.
Aug 26, 2026, 06:47 ET Alebund Pharmaceuticals Announces 2026 Interim Results
patient enrollment completed in the global Phase III pivotal multi-regional clinical trial; the New Drug Application in China accepted for review by the National Medical Products Administration of China (the "NMPA"). In May 2026, RESPOND-2, the global Phase III pivotal multi-regional clinical trial (the
More news about: Alebund Pharmaceuticals
Aug 26, 2026, 06:45 ET Target Hospitality Secures New Multi-Year Contract Expected to Generate Approximately $250 Million of Revenue to Support a Top-Five Hyperscaler Data Center Project
evaluate its operating performance; (ii) they are among the measures used by Target Hospitality's management team to make day-to-day operating decisions, (iii) they are frequently used by securities analysts, lenders, investors and other interested parties as a common performance measure and to compare results
More news about: Target Hospitality
Aug 26, 2026, 06:44 ET 禮邦醫藥發佈 2026 年中期業績
受性，並提升患者長期用藥依從性。進行中的全球 III 期關鍵性多區域臨床試驗（RESPOND-2，NCT06933472）：該研究為在美國及中國開展的隨機、雙盲、全球多區域 III 期臨床試驗，計劃入組 264 名年齡 12 歲及以上、接受維持性透析的高磷血症 CKD 患者，實際共入組 282 名（美國 138 名、中國 144 名）。基於 AP301 現有臨床數據，公司與 FDA 已就以該項全球 III 期多區域臨床試驗作為支持 AP301 在美國註冊的單項關鍵性研究達成一致。2026
More news about: 禮邦醫藥
Aug 26, 2026, 06:37 ET Commercialization Roadmap Validated with Three-digit Million-dollar Revenue: Insilico Medicine Announces Interim Results for the First Half of 2026
clinical validation:Rentosertib (ISM001-055): The core pipeline Rentosertib officially initiated a large-scale Phase III clinical trial in China for idiopathic pulmonary fibrosis (IPF) to evaluate the efficacy and safety of 52-week treatment.Rentosertib (Inhalation):
More news about: Insilico Medicine
Aug 26, 2026, 06:30 ET Hyperscale Data Subsidiary Gresham Worldwide Announces $5.4 Million in New Defense Sector Orders Bringing Backlog to Approximately $53.7 Million
programs require highly engineered components manufactured to stringent performance, reliability and qualification requirements.Milton "Todd" Ault III, Executive Chairman of Hyperscale Data, stated, "The approximately $5.4 million in new bookings during July and August represents encouraging momentum
More news about: Hyperscale Data Inc.
Aug 26, 2026, 05:17 ET Bitmine Immersion Technologies (BMNR) kondigt aan dat zijn ETH-holdings 5,85 miljoen tokens hebben bereikt en dat de totale holdings in cryptovaluta en liquide middelen 14,9 miljard dollar bedragen.
Bitmine wordt ondersteund door een vooraanstaande groep institutionele beleggers, waaronder Cathie Wood van ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital en privébelegger Thomas 'Tom' Lee, bij zijn doel om 5% van alle ETH te verwervenNORWALK,
More news about: Bitmine Immersion Technologies, Inc.
Aug 26, 2026, 05:06 ET Bitmine Immersion Technologies (BMNR) Mengumumkan Kepemilikan ETH Mencapai 5,85 Juta Token, serta Total Kepemilikan Kripto dan Kas Sebesar $14,9 Miliar
Bitmine terus mendapat dukungan dari kelompok investor institusional terkemuka, termasuk Cathie Wood dari ARK, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital, serta investor perorangan Thomas "Tom" Lee, untuk mendukung target Bitmine mengakuisisi 5% ETH
More news about: Bitmine Immersion Technologies, Inc.